Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

Clinical trial NCT07098806 · RECRUITING

Trial details

NCT number: NCT07098806
Sponsor: Plus Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leptomeningeal Metastasis

Start date: 2025-07-02
Primary completion: 2026-10-02
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.